XPH
State Street SPDR S&P Pharmaceuticals ETF
1W: +2.2%
1M: +6.2%
3M: +19.4%
YTD: +24.1%
1Y: +58.8%
3Y: +69.0%
5Y: +47.6%
$69.00
+0.46 (+0.67%)
Weekly Expected Move ±4.0%
$63
$65
$68
$71
$73
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Dividends
Weather
Key Statistics
AUM$278M
Holdings64
Top 10 Wt24.9%
Volume66,880
Avg Volume80,974
Beta0.72
Portfolio Fundamentals
P/E34.7
P/B8.2
Div Yield0.55%
ROE22.0%
% Profitable40%
Inception2006-06-19
Sector Allocation
Healthcare
99.9%
Other
0.1%
Top 10 Holdings
| # | Name | Ticker | Weight % | Market Value | Shares |
|---|---|---|---|---|---|
| 1 | CRINETICS PHARMACEUTICALS IN | CRNX | 3.70% | $17.7M | 209,955 |
| 2 | MBX BIOSCIENCES INC | MBX | 3.03% | $14.5M | 232,515 |
| 3 | ATAIBECKLEY INC | ATAI | 2.88% | $13.8M | 1,906,258 |
| 4 | DEFINIUM THERAPEUTICS INC | DFTX | 2.82% | $13.5M | 310,054 |
| 5 | ENLIVEN THERAPEUTICS INC | ELVN | 2.17% | $10.4M | 194,747 |
| 6 | NUVATION BIO INC | NUVB | 2.13% | $10.2M | 1,573,287 |
| 7 | ALUMIS INC | ALMS | 2.12% | $10.1M | 359,205 |
| 8 | AMYLYX PHARMACEUTICALS INC | AMLX | 2.07% | $9.9M | 535,338 |
| 9 | LIQUIDIA CORP | LQDA | 2.00% | $9.6M | 110,431 |
| 10 | TREVI THERAPEUTICS INC | TRVI | 1.98% | $9.5M | 537,735 |